Key Product Details

Species Reactivity

Validated:

Mouse

Cited:

Mouse

Applications

Validated:

Immunohistochemistry, Western Blot, Neutralization, Intracellular Staining by Flow Cytometry, CyTOF-ready

Cited:

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Neutralization, Flow Cytometry, Bioassay, ELISA Development, In vivo assay, Functional Assay

Label

Unconjugated

Antibody Source

Monoclonal Rat IgG2A Clone # 37895
Loading...

Product Specifications

Immunogen

E. coli-derived recombinant mouse IFN-gamma

Specificity

Detects mouse IFN-gamma in Western blots. In Western blots, this antibody does not cross-react with recombinant human (rh) IFN‑ gamma, rrIFN‑ gamma, rpIFN‑ gamma, rrmIFN‑ gamma, rfeIFN‑ gamma, or rcaIFN‑ gamma.

Clonality

Monoclonal

Host

Rat

Isotype

IgG2A

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Mouse IFN‑ gamma Antibody

Detection of IFN-? antibody in Mouse Splenoctyes antibody by Flow Cytometry.

Detection of IFN‑ gamma in Mouse Splenoctyes by Flow Cytometry.

Mouse splenocytes either (A) stimulated to induce Th1 cells or (B) unstimulated were stained with Rat Anti-Mouse IFN-gamma Monoclonal Antibody (Catalog # MAB485) followed by Phycoerythrin-conjugated Anti-Rat IgG Secondary Antibody (F0105B) and Rat Anti-Mouse CD4 APC-conjugated Monoclonal Antibody (FAB554A). Quadrant markers were set based on control antibody staining (MAB006). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (FC005). View our protocol for Staining Intracellular Molecules.

Detection of IFN‑ gamma in Mouse Splenoctyes by Flow Cytometry.

Mouse splenocytes either (A) stimulated for 4 hours with Cell Activation Cocktail 500x (5476) or (B) unstimulated were stained with Rat Anti-Mouse IFN-gamma Monoclonal Antibody (Catalog # MAB485) followed by Phycoerythrin-conjugated Anti-Rat IgG Secondary Antibody (F0105B) and Rat Anti-Mouse CD4 APC-conjugated Monoclonal Antibody (FAB554A). Quadrant markers were set based on control antibody staining (MAB006). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (FC005). Staining was performed using our Staining Intracellular Molecules protocol.
IFN‑ gamma  Inhibition of EMCV-induced Cytopathy and Neutralization by Mouse IFN‑ gamma  Antibody.

IFN‑ gamma Inhibition of EMCV-induced Cytopathy and Neutralization by Mouse IFN‑ gamma Antibody.

Recombinant Mouse IFN-gamma 485-MI) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the L-929 mouse fibroblast cell line in a dose-dependent manner (orange line), as measured by crystal violet staining. Inhibition of EMCV activity elicited by Recombinant Mouse IFN-gamma (2.5 ng/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Mouse IFN-gamma Monoclonal Antibody (Catalog # MAB485). The ND50 is typically 0.075-0.3 µg/mL.

Detection of IFN‑ gamma in Mouse Spleen.

IFN‑ gamma was detected in immersion fixed paraffin-embedded sections of Mouse Spleen using Rat Anti-Mouse IFN‑ gamma Monoclonal Antibody (Catalog # MAB485) at 10 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Rat IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC005). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using VisUCyte Antigen Retrieval Reagent-Basic (Catalog # VCTS021). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm in lymphocytes. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.
Detection of Mouse IFN-gamma by Flow Cytometry

Detection of Mouse IFN-gamma by Flow Cytometry

EAE induction in KO mice.(a) Means±s.e.m. of EAE clinical scores of KO and WT mice. *P<0.05 (two-tailed Student's t-test). (b) EAE incidence in KO and WT mice. *P<0.05 (chi-square test). (c) Means±s.e.m. of body weight of KO and WT mice during EAE induction. Body weight of mice on day 10 post-immunization was considered as 100%. *P<0.05 (two-tailed Student's t-test). (d) Means±s.e.m. of cellularity in draining LN and of cells infiltrating the CNS of mice 14 days after MOG immunization. Mouse numbers (n) and P values (paired two-tailed Student's t-test) are indicated. (e,f) Cytokine-producing cells among CD4 cells from draining LN (e) and CNS (f) on days 13–18 after MOG immunization. Left panels: representative dot plots; right panel: bar graphs (means±s.e.m.) summarizing all the results, with mouse numbers and P values (two-tailed Student's t-test) indicated. (g) HE (left column) or Luxol Fast Blue (right column) staining of spinal cords 30 days after MOG immunization. Asterisks indicate cell infiltration. Arrows point to demyelination. (h) Means±s.e.m. of mononuclear cell infiltration scores, demyelination scores and total pathological scores, which is the sum of the first two scores. Mouse numbers (n) and P values (two-tailed Student's t-test) are indicated. (i) Treg cells in naive KO mice on day 17 during EAE induction. Left panel: representative dot plots; right panel: means±s.e.m. of data from three experiments. NS: not significant (two-tailed Student's t-test). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28169274), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Mouse IFN-gamma by Flow Cytometry

Detection of Mouse IFN-gamma by Flow Cytometry

EAE induction in KO mice.(a) Means±s.e.m. of EAE clinical scores of KO and WT mice. *P<0.05 (two-tailed Student's t-test). (b) EAE incidence in KO and WT mice. *P<0.05 (chi-square test). (c) Means±s.e.m. of body weight of KO and WT mice during EAE induction. Body weight of mice on day 10 post-immunization was considered as 100%. *P<0.05 (two-tailed Student's t-test). (d) Means±s.e.m. of cellularity in draining LN and of cells infiltrating the CNS of mice 14 days after MOG immunization. Mouse numbers (n) and P values (paired two-tailed Student's t-test) are indicated. (e,f) Cytokine-producing cells among CD4 cells from draining LN (e) and CNS (f) on days 13–18 after MOG immunization. Left panels: representative dot plots; right panel: bar graphs (means±s.e.m.) summarizing all the results, with mouse numbers and P values (two-tailed Student's t-test) indicated. (g) HE (left column) or Luxol Fast Blue (right column) staining of spinal cords 30 days after MOG immunization. Asterisks indicate cell infiltration. Arrows point to demyelination. (h) Means±s.e.m. of mononuclear cell infiltration scores, demyelination scores and total pathological scores, which is the sum of the first two scores. Mouse numbers (n) and P values (two-tailed Student's t-test) are indicated. (i) Treg cells in naive KO mice on day 17 during EAE induction. Left panel: representative dot plots; right panel: means±s.e.m. of data from three experiments. NS: not significant (two-tailed Student's t-test). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28169274), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Mouse IFN-gamma by Flow Cytometry

Detection of Mouse IFN-gamma by Flow Cytometry

Proliferation and differentiation of naive KO CD4 cells into Th1 and Th17 cells.(a) Proliferation of WT and KO naive spleen CD4 cells under Th1 and Th17 conditions was assessed based on CFSE content according to flow cytometry. Experiments were conducted three times, and representative histograms are shown. Grey peaks represent the CFSE content of CD4 cells at day 0. (b) These cells' differentiation into Th1 and Th17 cells was also determined by flow cytometry according to intracellular IFN-gamma and IL-17 positivity (gated on total CD4+). Representative dot plots are shown in the left panel. Means±s.e.m. of data from three experiments are presented as bar graphs in the right panel. Mouse numbers (n) per group are indicated. P values are reported in the bar graphs (two-tailed Student's t-test). (c,d) T-bet and ROR gamma t expression in CD4 cells cultured under Th1 and Th17 conditions or in IFN gamma + or IL-17+ cells was determined by flow cytometry. Experiments were conducted three times. Representative histograms are shown. (e) Th1 and Th17 differentiation of naive spleen CD4 cells (CD45.2 single-positive) derived from WT and KO donors in chimeric mice was analysed by flow cytometry based on their intracellular IFN-gamma and IL-17 expression. Representative dot plots are shown in the left panel. Means±s.e.m. of data from three experiments are presented as bar graphs in the right panel. Mouse numbers (n) per group are indicated. p values are reported in the bar graphs (two-tailed Student's t-test). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28169274), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Mouse IFN-gamma by Flow Cytometry

Detection of Mouse IFN-gamma by Flow Cytometry

Proliferation and differentiation of naive KO CD4 cells into Th1 and Th17 cells.(a) Proliferation of WT and KO naive spleen CD4 cells under Th1 and Th17 conditions was assessed based on CFSE content according to flow cytometry. Experiments were conducted three times, and representative histograms are shown. Grey peaks represent the CFSE content of CD4 cells at day 0. (b) These cells' differentiation into Th1 and Th17 cells was also determined by flow cytometry according to intracellular IFN-gamma and IL-17 positivity (gated on total CD4+). Representative dot plots are shown in the left panel. Means±s.e.m. of data from three experiments are presented as bar graphs in the right panel. Mouse numbers (n) per group are indicated. P values are reported in the bar graphs (two-tailed Student's t-test). (c,d) T-bet and ROR gamma t expression in CD4 cells cultured under Th1 and Th17 conditions or in IFN gamma + or IL-17+ cells was determined by flow cytometry. Experiments were conducted three times. Representative histograms are shown. (e) Th1 and Th17 differentiation of naive spleen CD4 cells (CD45.2 single-positive) derived from WT and KO donors in chimeric mice was analysed by flow cytometry based on their intracellular IFN-gamma and IL-17 expression. Representative dot plots are shown in the left panel. Means±s.e.m. of data from three experiments are presented as bar graphs in the right panel. Mouse numbers (n) per group are indicated. p values are reported in the bar graphs (two-tailed Student's t-test). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28169274), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Mouse IFN-gamma by Flow Cytometry

Detection of Mouse IFN-gamma by Flow Cytometry

CpG-2722 treatment increases PS exposure on cancer through induction of cytokines from immune. (A) Mouse splenocytes were stimulated with/without 5 μg/ml of CpG-2722 for 48 h, & collected the condition medium (C.M.). NHRI-HN1 were treatment with/without 5 μg/ml of CpG-2722 or with/without medium containing 25% C.M. for 24 h as illustrated in the top panel. Phosphatidylserine (PS) exposure on NHRI-HN1 were stained by annexin V conjugated APC antibody, & acquired on a FACS Canto II & analyzed using FlowJo software. Bottom left panel: a representative set of histograms. Bottom right panel: Data represent the mean ± SEM (n = 3). (B) Cytokine levels of TNF-alpha, IFN-gamma, & Trail in tumors from the experiment in Figure 5 were measured by ELISA. Data represent the mean ± SEM (n = 5). (C) NHRI-HN1 were treated with 100 ng/ml of TNF-alpha, IFN-gamma, or Trail for 24 h. Levels of PS exposure were stained by annexin V conjugated APC antibody & acquired on a FACS Canto II. Left panel: a representative set of histograms. Right panel: Data represent the mean ± SEM (n = 3). (D) Mouse splenocytes were stimulated with/without 5 μg/ml of CpG-2722 for 48 h, & the C.M. was collected. NHRI-HN1 were incubated with medium containing 25% of the C.M. in the presence of 1 μg/ml of neutralizing antibody to TNF-alpha, IFN-gamma, Trail or their combination as indicated for 24 h. Phosphatidylserine (PS) exposure on NHRI-HN1 were stained by annexin V conjugated APC antibody, & acquired on a FACS Canto II & analyzed using FlowJo software. Bottom left panel: a representative set of histograms. Bottom right panel: Data represent the mean ± SEM (n = 3). *, **, & *** represent statistically significant differences p < 0.05, p < 0.01, & p < 0.001, respectively, compared with the control or as indicated. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37324949), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Mouse IFN-gamma by Flow Cytometry

Detection of Mouse IFN-gamma by Flow Cytometry

CpG-2722 treatment increases PS exposure on cancer through induction of cytokines from immune. (A) Mouse splenocytes were stimulated with/without 5 μg/ml of CpG-2722 for 48 h, & collected the condition medium (C.M.). NHRI-HN1 were treatment with/without 5 μg/ml of CpG-2722 or with/without medium containing 25% C.M. for 24 h as illustrated in the top panel. Phosphatidylserine (PS) exposure on NHRI-HN1 were stained by annexin V conjugated APC antibody, & acquired on a FACS Canto II & analyzed using FlowJo software. Bottom left panel: a representative set of histograms. Bottom right panel: Data represent the mean ± SEM (n = 3). (B) Cytokine levels of TNF-alpha, IFN-gamma, & Trail in tumors from the experiment in Figure 5 were measured by ELISA. Data represent the mean ± SEM (n = 5). (C) NHRI-HN1 were treated with 100 ng/ml of TNF-alpha, IFN-gamma, or Trail for 24 h. Levels of PS exposure were stained by annexin V conjugated APC antibody & acquired on a FACS Canto II. Left panel: a representative set of histograms. Right panel: Data represent the mean ± SEM (n = 3). (D) Mouse splenocytes were stimulated with/without 5 μg/ml of CpG-2722 for 48 h, & the C.M. was collected. NHRI-HN1 were incubated with medium containing 25% of the C.M. in the presence of 1 μg/ml of neutralizing antibody to TNF-alpha, IFN-gamma, Trail or their combination as indicated for 24 h. Phosphatidylserine (PS) exposure on NHRI-HN1 were stained by annexin V conjugated APC antibody, & acquired on a FACS Canto II & analyzed using FlowJo software. Bottom left panel: a representative set of histograms. Bottom right panel: Data represent the mean ± SEM (n = 3). *, **, & *** represent statistically significant differences p < 0.05, p < 0.01, & p < 0.001, respectively, compared with the control or as indicated. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37324949), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Mouse IFN‑ gamma Antibody

Application
Recommended Usage

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Immunohistochemistry

5-15 µg/mL
Sample: Immersion fixed paraffin-embedded sections of Mouse Spleen

Intracellular Staining by Flow Cytometry

0.25 µg/106 cells
Sample: Mouse splenocytes stimulated to induce Th1 cells or for 4 hours with Cell Activation Cocktail 500x (5476) were fixed with Flow Cytometry Fixation Buffer (Catalog # FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (Catalog # FC005)

Western Blot

1 µg/mL
Sample: Recombinant Mouse IFN-gamma (Catalog # 485-MI)

Neutralization

Measured by its ability to neutralize IFN‑ gamma inhibition of EMCV-induced cytopathy in the L‑929 mouse fibroblast cell line. Vogel, S. and M. Hogan (1995) in Current Protocols in Immunology. Ciocio, R. (ed); John Wiley & Sons, Inc. p. 6. 9. 1. The Neutralization Dose (ND50) is typically 0.075-0.3 µg/mL in the presence of 2.5 ng/mL Recombinant Mouse IFN‑ gamma.

Flow Cytometry Panel Builder

Bio-Techne Knows Flow Cytometry

Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.

Advanced Features

  • Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
  • Spillover Popups - Visualize the spectra of individual fluorochromes
  • Antigen Density Selector - Match fluorochrome brightness with antigen density
Build Your Panel Now

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: IFN-gamma

Interferon-gamma (IFN-gamma, IFNG), also known as type II or Immune Interferon, exerts a wide range of immunoregulatory activities and is considered to be the prototype proinflammatory cytokine. Mature human IFN-gamma exists as a non-covalently linked homodimer of 20-25 kDa molecular weight variably glycosylated subunits. It shares 86% amino acid (aa) sequence identity with rat IFN-gamma, 38-44% with bovine, canine, cotton rat, equine, feline, human, porcine and rhesus IFN‑ gamma. IFN-gamma dimers bind to IFN-gamma RI (alpha subunits) which then interact with IFN-gamma RII (beta subunits) to form the functional receptor complex of two alpha and two beta subunits. Inclusion of IFN-gamma RII increases the binding affinity for ligand and the efficiency of signal transduction. IFN-gamma is produced by a variety of immune cells under inflammatory conditions, notably by T cells and NK cells. It plays a key function in host defense by promoting the development and activation of Th1 cells, chemoattraction and activation of monocytes and macrophages, up‑regulation of antigen presentation molecules, and immunoglobulin class switching in B cells. It also exhibits antiviral, antiproliferative, and apoptotic effects. In addition, IFN-gamma functions as an anti-inflammatory mediator by promoting the development of regulatory T cells and inhibiting Th17 cell differentiation. The pleiotropic effects of IFN-gamma contribute to the development of multiple aspects of atherosclerosis.

Long Name

Interferon gamma

Alternate Names

IFG, IFI, IFNG, IFNgamma

Entrez Gene IDs

3458 (Human); 15978 (Mouse); 25712 (Rat); 396991 (Porcine); 281237 (Bovine); 403801 (Canine); 493965 (Feline)

Gene Symbol

IFNG

Additional IFN-gamma Products

Product Documents for Mouse IFN‑ gamma Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Mouse IFN‑ gamma Antibody

For research use only

Citations for Mouse IFN‑ gamma Antibody

Customer Reviews for Mouse IFN‑ gamma Antibody

There are currently no reviews for this product. Be the first to review Mouse IFN‑ gamma Antibody and earn rewards!

Have you used Mouse IFN‑ gamma Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies